Evidence map›Paper›PMID 28508233›Full record

Trial reportWorld journal of surgery2017

Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.

Benjamin Weixler, Andreas Rickenbacher, Dimitri Aristotle Raptis, Carsten T Viehl, Ulrich Guller, Jessica Rueff, Andreas Zettl, Markus Zuber

Abstract readClinical TrialComparative Study
PubMed Publisher
In one paragraph

Trial report in World journal of surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. The Value of Sentinel Lymph Node Mapping for the Staging of Node-Negative Colon Cancer: Propensity Score and Mediation Analyses.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2021
    Article
  12. Role of near-infrared fluorescence in colorectal surgery.World journal of gastroenterology · 2021
    Review
  13. Review
  14. Article
  15. Scientific reports · 2020
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Benjamin WeixlerDepartment of Surgery, University Hospital Basel, Basel, Switzerland.
Andreas RickenbacherDepartment of Surgery, Kantonsspital Olten, 4600, Olten, Switzerland.
Dimitri Aristotle RaptisDepartment of Surgery, Kantonsspital Olten, 4600, Olten, Switzerland.
Carsten T ViehlDepartment of Surgery, Hospital Center Biel, Biel/Bienne, Switzerland.
Ulrich GullerDivision of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Jessica RueffDepartment of Surgery, Kantonsspital Olten, 4600, Olten, Switzerland.
Andreas ZettlViollier AG, Histopathology/Cytology, Basel, Switzerland.
Markus ZuberDepartment of Surgery, Kantonsspital Olten, 4600, Olten, Switzerland. markus.zuber@spital.so.ch.
Kantonsschule Olten · CHIn Silico Toxicology (Switzerland) · CHSpitalzentrum Centre hospitalier Biel- Bienne · CHUniversity Hospital of Basel · CHUniversity Hospital of Bern · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSentinel lymph node (SLN) mapping was reported to improve lymph node staging in colon cancer. This study compares isosulfan blue (IB) with indocyanine green (ICG)-based SLN-mapping and assesses the prognostic value of isolated tumor cells (ITC) and micro-metastases in upstaged patients.

methodsA total of 220 stage I-III colon cancer patients were included in this prospective single-center study. In 170 patients, SLN-mapping was performed in vivo with IB and in 50 patients ex vivo with ICG. Three levels of each SLN were stained with H&E. If negative for tumor infiltration, immunostaining for cytokeratin (AE1/3; cytokeratin-19) was performed.

resultsSLN detection rate for IB and ICG was 100 and 98%, respectively. Accuracy and sensitivity was 88 and 75% for IB, 82 and 64% for ICG, respectively (p = 0.244). Overall, 149 (68%) patients were node negative. In these patients, ITC and micro-metastases were detected in 26% (31/129) with IB and 17% (5/29) with ICG (p = 0.469). Patients with ITC and micro-metastases did show decreased overall survival (hazard ratio = 1.96, p = 0.09) compared to node negative disease.

conclusionsThis study demonstrates a high diagnostic accuracy for both the IB and the ICG SLN-mapping. SLN-mapping upstaged a quarter of patients with node negative colon cancer, and the detected ITC and micro-metastases were an independent negative prognostic marker in multivariate analysis.

Indexed as

Coloring AgentsIndocyanine GreenRosaniline DyesAgedAged, 80 and overColonic NeoplasmsFemaleHumansKeratin-19MaleMiddle AgedNeoplasm MicrometastasisNeoplasm StagingPrognosisProspective StudiesSentinel Lymph NodeColoring AgentsIndocyanine Greeniso-sulfan blueKeratin-19Rosaniline Dyes

Identifiers

PMID28508233
OpenAlexW2614826817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.